Recombinant human thrombopoietin (rh-TPO) is generally used for treating thrombocytopenia caused by chemotherapy and immune thrombocytopenia (Vadhan-Raj et al., 2003; Yu et al., 2020). The gene discussed is THPO; the disease is Thrombocytopenia.